EN - Anglická CZ - Česká SK - Slovenská PL - Polská RO - Rumunská RU - Ruská TR - Turecká UA - Ukrajinská
EN - Anglická
  • CZ - Česká
  • SK - Slovenská
  • PL - Polská
  • RO - Rumunská
  • RU - Ruská
  • TR - Turecká
  • UA - Ukrajinská

CVDL Mexico: Protecting the Health of People and Animals through Dog Vaccination

Homepage News What´s new? CVDL Mexico: Protecting the Health of People and Animals through Dog Vaccination

7.10.2025

CVDL Mexico: Protecting the Health of People and Animals through Dog Vaccination Bioveta actively participated in one of the largest global veterinary congresses and the largest in the Hispanic world: Congreso Veterinario de León (CVDL) in Mexico.

The congress is known for its extensive professional program. The 30th anniversary edition attracted a total of 22,748 participants from September 3 to 6, 2025. Dr. Alberto Velásquez presented Bioveta, a traditional manufacturer of veterinary vaccines based in the Czech Republic, delivering vaccines worldwide. He highlighted the societal benefits of dog vaccination, which reduces the risk of leptospirosis and rabies infections in the human population. Our presence was supported by CzechTrade and the Czech Embassy in Mexico.

The One Health concept benefits not only people but also dogs, cats, and other animals. It is based on the idea that the health of people, animals, and the environment is interconnected. It promotes knowledge sharing, responsible approaches, and interdisciplinary collaboration that accelerates progress in health protection on a global scale. Bioveta shares this approach and considers it an integral part of its existence. With modern production concentrated in one location in the Czech Republic, utilizing the latest technologies, sustainable principles, and in-house vaccine development, we provide products that protect animal health and, indirectly, human health worldwide. Our rabies vaccines are used in dogs, cats, livestock, and wildlife. Bioveta has significantly contributed to the recovery of the Czech Republic and other European countries from this deadly zoonotic disease. We also focus on vaccines against the most common strains of the life-threatening bacterium Leptospira, which threatens not only the dog population but also human health. High vaccination rates in the dog population, as confirmed by numerous scientific publications, significantly reduce the incidence of leptospirosis in humans as well. It was an honor and a pleasure for us to accept the invitation to actively participate in this global congress and present our daily work to the participants.

   



Share: tw.png, 637B fb3.png, 512B gg.png, 716B in.png, 595B